GSK, with confirmatory trial win, looks to expand PD-1 Jemperli in endometrial cancer - FiercePharma

Submitted by Anonymous (not verified) on Fri, 12/02/2022 - 16:59

GSK, with confirmatory trial win, looks to expand PD-1 Jemperli in endometrial cancer  FiercePharma